Skip to main content
. Author manuscript; available in PMC: 2012 May 15.
Published in final edited form as: Cancer Res. 2011 Apr 6;71(10):3563–3572. doi: 10.1158/0008-5472.CAN-10-3568

Figure 5.

Figure 5

Inhibition of miR-10b reduces glioma growth in vivo in U87 mouse model. A, Mice with established subcutaneous U87 tumors were injected intratumorally with either inhibitor of miR-10b or corresponding control oligo at days indicated by arrows. Tumor growth was monitored by in vivo Fluc bioluminescence imaging. Each data point represents the mean ±SD. B, Established U87 tumors were injected with either control or miR-10b inhibitor for two days in a row. Two days later, mice were sacrificed and tumors were removed, sectioned, and stained for nuclei using DAPI (blue) and Ki-67 (green).